The regulatory overhead to getting a drug approved by the FDA is enormous and this places a huge burden on small companies. I have no magic ideas for fixing th

The regulatory overhead to getting a drug approved by the FDA is enormous and this places a huge burden on small companies. I have no magic ideas for fixing this but it's a classic problem of regulatory capture, in many other fields besides pharmaceuticals. I suspect there are ways that the government (and/or private funders) could effectively centralize just the testing and data collection, while keeping the R&D independent and flexible, but it would require a different mindset than we usually apply to public policy.